Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Munzel

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Atherosclerosis|January 20, 2009
Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR studyMir Abolfazl Ostad, Silke Eggeling, Peter Tschentscher, et al.
Free Radical Biology & Medicine|April 25, 2006
Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2Andrei L Kleschyov, Susanne Strand, Steffen Schmitt, et al.
Circulation|August 14, 2008
Different calculations of ankle-brachial index and their impact on cardiovascular risk predictionChristine Espinola-Klein, Hans J Rupprecht, Christoph Bickel, et al.
Journal of Clinical Medicine|November 27, 2021
Effectiveness of a Real-Time X-ray Dosimetry Monitor in Reducing Radiation Exposure in Coronary Procedures: The ESPRESSO-Raysafe Randomized TrialMaximilian Olschewski, Helen Ullrich, Moritz Brandt, et al.
Clinical Hemorheology and Microcirculation|April 10, 2018
Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1Remzi Anadol, Zisis Dimitriadis, Alberto Polimeni, et al.
The American Journal of Cardiology|March 14, 2007
Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosisChristine Espinola-Klein, Hans J Rupprecht, Christoph Bickel, et al.
Atherosclerosis|September 15, 2006
AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery diseaseAscan Warnholtz, Mir Abolfazl Ostad, Thomas Heitzer, et al.
European Journal of Pharmacology|June 21, 2005
Nomega-hydroxy-L-arginine homologues and hydroxylamine as nitric oxide-dependent vasorelaxant agentsPetra Beranova, Karel Chalupsky, Andrei L Kleschyov, et al.
Atherosclerosis|September 30, 2008
Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF studyAscan Warnholtz, Philipp Wild, Mir Abolfazl Ostad, et al.
BMC Medical Genetics|November 10, 2012
Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: the Athero Gene studyChoumous Kallel, William Cohen, Noémie Saut, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Atherosclerosis|January 20, 2009
Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR studyMir Abolfazl Ostad, Silke Eggeling, Peter Tschentscher, et al.
Free Radical Biology & Medicine|April 25, 2006
Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2Andrei L Kleschyov, Susanne Strand, Steffen Schmitt, et al.
Circulation|August 14, 2008
Different calculations of ankle-brachial index and their impact on cardiovascular risk predictionChristine Espinola-Klein, Hans J Rupprecht, Christoph Bickel, et al.
Journal of Clinical Medicine|November 27, 2021
Effectiveness of a Real-Time X-ray Dosimetry Monitor in Reducing Radiation Exposure in Coronary Procedures: The ESPRESSO-Raysafe Randomized TrialMaximilian Olschewski, Helen Ullrich, Moritz Brandt, et al.
Clinical Hemorheology and Microcirculation|April 10, 2018
Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1Remzi Anadol, Zisis Dimitriadis, Alberto Polimeni, et al.
The American Journal of Cardiology|March 14, 2007
Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosisChristine Espinola-Klein, Hans J Rupprecht, Christoph Bickel, et al.
Atherosclerosis|September 15, 2006
AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery diseaseAscan Warnholtz, Mir Abolfazl Ostad, Thomas Heitzer, et al.
European Journal of Pharmacology|June 21, 2005
Nomega-hydroxy-L-arginine homologues and hydroxylamine as nitric oxide-dependent vasorelaxant agentsPetra Beranova, Karel Chalupsky, Andrei L Kleschyov, et al.
Atherosclerosis|September 30, 2008
Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF studyAscan Warnholtz, Philipp Wild, Mir Abolfazl Ostad, et al.
BMC Medical Genetics|November 10, 2012
Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: the Athero Gene studyChoumous Kallel, William Cohen, Noémie Saut, et al.
Pageof 9